KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for Eli Lilly (LLY) over the last 17 years, with Q3 2025 value amounting to $114.9 billion.

  • Eli Lilly's Liabilities and Shareholders Equity rose 5201.71% to $114.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $384.0 billion, marking a year-over-year increase of 3940.37%. This contributed to the annual value of $78.7 billion for FY2024, which is 2297.99% up from last year.
  • Latest data reveals that Eli Lilly reported Liabilities and Shareholders Equity of $114.9 billion as of Q3 2025, which was up 5201.71% from $100.9 billion recorded in Q2 2025.
  • In the past 5 years, Eli Lilly's Liabilities and Shareholders Equity ranged from a high of $114.9 billion in Q3 2025 and a low of $46.8 billion during Q1 2021
  • Over the past 5 years, Eli Lilly's median Liabilities and Shareholders Equity value was $54.8 billion (recorded in 2023), while the average stood at $63.6 billion.
  • As far as peak fluctuations go, Eli Lilly's Liabilities and Shareholders Equity crashed by 155.91% in 2022, and later soared by 5201.71% in 2025.
  • Eli Lilly's Liabilities and Shareholders Equity (Quarter) stood at $48.8 billion in 2021, then grew by 1.4% to $49.5 billion in 2022, then rose by 29.33% to $64.0 billion in 2023, then grew by 22.98% to $78.7 billion in 2024, then soared by 46.01% to $114.9 billion in 2025.
  • Its last three reported values are $114.9 billion in Q3 2025, $100.9 billion for Q2 2025, and $89.4 billion during Q1 2025.